Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2023 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes

NEW HOPE, Pa., June 26, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
June 07, 2023 08:30 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer

Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to forge further strategic collaborations in newly...
June 01, 2023 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Present at the Jefferies Global Healthcare Conference

NEW HOPE, Pa., June 01, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
May 12, 2023 09:15 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update

Completed business combination and listing on Nasdaq generating gross proceeds of approximately $70 millionBackBeat CNT™ global pivotal study in hypertensive pacemaker patients on track for initiation...
March 07, 2023 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Present at Upcoming Investor Conferences

NEW HOPE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
February 24, 2023 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT™ and Virtue® SAB at CRT 2023

NEW HOPE, Pa., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
February 07, 2023 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Strengthens Senior Leadership Team

Avi Fischer, M.D., joins as SVP, Medical Affairs and Innovation; J.C. Simeon assumes role of SVP, Quality George Papandreou, Ph.D., promoted to General Manager and SVP, Focal Therapies; Kunal Faldu...
January 27, 2023 08:00 ET | Source: Orchestra BioMed, Inc.

Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model

Business combination with Health Sciences Acquisitions Corporation 2, a special purpose acquisition company sponsored by an affiliate of RTW Investments, LP, completed on January 26, 2023 The...